Urethral cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Gender) |
(→Race) |
||
| Line 16: | Line 16: | ||
===Race=== | ===Race=== | ||
* [[Urethral]] [[cancer]] usually affects African American individuals. | * [[Urethral]] [[cancer]] usually affects [[African-Caribbean Leukaemia Trust|African]] [[American Academy of Allergy, Asthma, and Immunology|American]] individuals. | ||
==References== | ==References== | ||
Revision as of 13:50, 19 June 2018
|
Urethral cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Urethral cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Urethral cancer epidemiology and demographics |
|
Risk calculators and risk factors for Urethral cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
Urethral cancer is a rare disease that tends to affect African American individuals. The incidence is approximately 0.43 per 100,000 in the United States for men, and approximately 0.15 per 100,000 for women.
Epidemiology and Demographics
Incidence
- Urethral cancer is rare.[1]
- The annual incidence rates in the Surveillance, Epidemiology, and End Results database over the period from 1973 to 2002 in the United States for men and for women were 4.3 and 1.5 per million, respectively, with downward trends over the three decades.
- The incidence was twice as high in African Americans as in whites (5 million vs. 2.5 per million).
Gender
Race
References
- ↑ National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq